Research@StAndrews
 
The University of St Andrews

Research@StAndrews:FullText >
University of St Andrews Research >
University of St Andrews Research >
University of St Andrews Research >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10023/3282
This item has been viewed 1 times in the last year. View Statistics

Files in This Item:

File Description SizeFormat
ballester3196.pdf1.66 MBAdobe PDFView/Open
Title: Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification
Authors: Ballester, Pedro
Mangold, Martina
Howard, Nigel
Marchese Robinson, Richard
Abell, Chris
Blumberger, Jochen
Mitchell, John B. O.
Keywords: Virtual screening
Antibacterial hit identification
Chemoinformatics
Bioinformatics
Machine learning
High-throughput screening
QD Chemistry
Issue Date: 7-Dec-2012
Citation: Ballester , P , Mangold , M , Howard , N , Marchese Robinson , R , Abell , C , Blumberger , J & Mitchell , J B O 2012 , ' Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification ' Journal of the Royal Society Interface , vol 9 , no. 77 , pp. 3196-3207 .
Abstract: One of the initial steps of modern drug discovery is the identification of small organic molecules able to inhibit a target macromolecule of therapeutic interest. A small proportion of these hits are further developed into lead compounds, which in turn may ultimately lead to a marketed drug. A commonly used screening protocol used for this task is high-throughput screening (HTS). However, the performance of HTS against antibacterial targets has generally been unsatisfactory, with high costs and low rates of hit identification. Here, we present a novel computational methodology that is able to identify a high proportion of structurally diverse inhibitors by searching unusually large molecular databases in a time-, cost- and resource-efficient manner. This virtual screening methodology was tested prospectively on two versions of an antibacterial target (type II dehydroquinase from Mycobacterium tuberculosis and Streptomyces coelicolor), for which HTS has not provided satisfactory results and consequently practically all known inhibitors are derivatives of the same core scaffold. Overall, our protocols identified 100 new inhibitors, with calculated Ki ranging from 4 to 250 μM (confirmed hit rates are 60% and 62% against each version of the target). Most importantly, over 50 new active molecular scaffolds were discovered that underscore the benefits that a wide application of prospectively validated in silico screening tools is likely to bring to antibacterial hit identification.
Version: Publisher PDF
Status: Peer reviewed
URI: http://hdl.handle.net/10023/3282
http://rsif.royalsocietypublishing.org/content/early/2012/08/23/rsif.2012.0569.abstract
DOI: http://dx.doi.org/10.1098/rsif.2012.0569
ISSN: 1742-5689
Type: Journal article
Rights: This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Appears in Collections:Biomedical Sciences Research Complex (BSRC) Research
Chemistry Research
University of St Andrews Research



This item is protected by original copyright

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2012  Duraspace - Feedback
For help contact: Digital-Repository@st-andrews.ac.uk | Copyright for this page belongs to St Andrews University Library | Terms and Conditions (Cookies)